Literature DB >> 11272205

beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes.

D L Eizirik1, M I Darville.   

Abstract

Increased evidence suggests that apoptosis is the main mode of beta-cell death in early type 1 diabetes. Cytokines mediate beta-cell apoptosis, and in this article, we discuss some of the cytokine-modified genes that may contribute to beta-cell survival or death. The gene encoding for the inducible form of nitric oxide synthase is induced by interleukin (IL)-1beta or IL-1beta plus gamma-interferon in rodent and human islets, respectively. This leads to nitric oxide (NO) formation, which contributes to a major extent to beta-cell necrosis and to a minor extent to the process of beta-cell apoptosis. The main mode of cell death induced by cytokines in human beta-cells is apoptosis, whereas cytokines lead to both necrosis and apoptosis in rat and mouse beta-cells. It is suggested that the necrotic component in rodent islets is due to NO-induced mitochondrial impairment and consequent decreased ATP production. Human islets, possessing better antioxidant defenses, are able to preserve glucose oxidation and ATP production, and can thus complete the apoptotic program after the death signal delivered by cytokines. We propose that this death signal results from cytokine-induced parallel and/or sequential changes in the expression of multiple proapoptotic and prosurvival genes. The identity of these "gene modules" and of the transcription factors regulating them remains to be established.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272205     DOI: 10.2337/diabetes.50.2007.s64

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  43 in total

1.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

2.  β cell death and dysfunction during type 1 diabetes development in at-risk individuals.

Authors:  Kevan C Herold; Sahar Usmani-Brown; Tara Ghazi; Jasmin Lebastchi; Craig A Beam; Melena D Bellin; Michel Ledizet; Jay M Sosenko; Jeffrey P Krischer; Jerry P Palmer
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 3.  Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis.

Authors:  G Dahlquist
Journal:  Diabetologia       Date:  2005-12-14       Impact factor: 10.122

4.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 5.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

6.  The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  J Endocrinol       Date:  2008-06-18       Impact factor: 4.286

Review 7.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

8.  Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.

Authors:  Jon G Mabley; Alex Rabinovitch; Wilma Suarez-Pinzon; György Haskó; Pál Pacher; Robert Power; Gary Southan; Andrew Salzman; Csaba Szabó
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

9.  Redox modulation protects islets from transplant-related injury.

Authors:  Martha M Sklavos; Suzanne Bertera; Hubert M Tse; Rita Bottino; Jing He; Joshua N Beilke; Marilyne G Coulombe; Ronald G Gill; James D Crapo; Massimo Trucco; Jon D Piganelli
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

10.  Inhibition of the nuclear factor-κB pathway prevents beta cell failure and diet induced diabetes in Psammomys obesus.

Authors:  Josefine Friberg; Morten F Tonnesen; Schott Heller; Flemming Pociot; Thóra B Bödvarsdottir; Allan E Karlsen
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.